You are here

Scholar Rock

Scholar Rock scores with ‘surprise’ success in SMA drug study

BioPharma Dive

Mon, 10/7/24 - 11:52 am

spinal muscular atrophy

Scholar Rock gets FDA nod to trial SMA drug with GLP-1ra in obesity

Clinical Trials Arena

Wed, 01/24/24 - 10:38 am

clinical trials

Spinal Muscular Atrophy: Four trials to watch over the next 12 months

Clinical Trials Arena

Fri, 08/11/23 - 11:39 am

clinical trials

spinal muscular atrophy

JPM Day 2: Highlights

BioSpace

Tue, 01/10/23 - 06:50 pm

Relay Therapeutics

SAGE Therapeutics

Karuna Therapeutics

Scholar Rock in a hard place as biotech lays off 25% of staff, narrows pipeline and loses CMO

Fierce Biotech

Tue, 05/17/22 - 10:45 am

spinal muscular atrophy

Scholar Rock eyes phase 3 after confirming effects of SMA drug

Fierce Biotech

Tue, 04/6/21 - 10:28 am

clinical trials

Biotech’s important clinical data readouts

EP Vantage

Fri, 03/26/21 - 10:35 am

spinal muscular atrophy

Primary Hyperoxaluria

Gilead Ends Year With Two Major Deals That Could Total More Than $3.125 Billion

BioSpace

Thu, 12/20/18 - 12:12 pm

Gilead Sciences

immuno-oncology

Gilead dangles $105M in quick cash to sign Scholar Rock to a discovery deal for its growing NASH pipeline

Endpoints

Wed, 12/19/18 - 10:39 am

Gilead Sciences

Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined

Xconomy

Thu, 05/24/18 - 11:51 am

Kiniksa Pharmaceuticals

Cambridge biotech startup to focus on muscle diseases with first drug

Bizjournals.com

Wed, 09/23/15 - 10:08 am

J&J Innovation launches a discovery pact with fledgling upstart Scholar Rock

Fierce Biotech

Wed, 01/8/14 - 09:39 am

autoimmune disease